Gail J. Roboz, M.D. | Aplastic Anemia & MDS International Foundation

Gail J. Roboz, M.D.

Position / Title: 
Director of the Clinical and Translational Leukemia Programs
Institution: 
New York Presbyterian Hospital
Primary Disease Area of Focus: 
  • acute myeloid leukemia (AML)
  • aplastic anemia
  • myelodysplastic syndromes (MDS)
  • myeloproliferative neoplasms (MPN)
  • paroxysmal nocturnal hemoglobinuria (PNH)
Other Disease Area(s) of Focus: 
Acute lymphocytic leukemia

Gail J. Roboz, M.D. is a professor of medicine and Director of the Clinical and Translational Leukemia Programs at the Weill Medical College of Cornell University and the NewYork Presbyterian Hospital in New York City. 

Dr. Roboz graduated summa cum laude from Yale University and received her medical degree from The Mount Sinai School of Medicine in New York, where she was elected to the Alpha Omega Alpha Honor Medical Society and achieved the highest academic standing in the graduating class.  She completed her internship in internal medicine at The Beth Israel Hospital in Boston and a residency in internal medicine at the New York Presbyterian Hospital. Dr. Roboz was a fellow in hematology and medical oncology at Weill Cornell/NewYork-Presbyterian Hospital and is board-certified in both specialties. She is a member of the American Society of Hematology and the American Society of Clinical Oncology.  Her research interests are in developmental therapeutics for acute leukemia, myelodysplastic syndrome, and myeloproliferative disorders. Dr. Roboz is the principal investigator on investigator-initiated and industry-sponsored clinical trials in these areas and has authored or coauthored many manuscripts and abstracts.  She sits on the editorial boards of and acts as a reviewer for several journals, and has played an active role as a speaker and panelist at numerous regional, national, and international conferences. Dr. Roboz is also one of the six principal investigators for the Edward P. Evans MDS Clinical Research Consortium.

Practice Location: 
New York Presbyterian Hospital
New York City , NY 10021
US
Physician Status: 
  • accepting new patients